Liquid biopsy consists of the analysis of peripheral blood sample or any other biologic liquid (saliva, cerebrospinal fluid, urine, etc.) for diagnostic or prognostic purposes, in different types of tumors.
Tethis’ SBS-CTC platform allows an investigation from enumeration of CTCs (circulating tumor cells) to target sequencing (NGS) without any pre-selection, allowing a CTC’s total capture.
SBS-CTC unparalleled performances
- No preselection method
- Total tumor cell capture
- Physiological features “in vitro” as “in vivo”
- Capture sensitivity up to 99%
- High specificity
- Minimal sample manipulation